Cite
APA Citation
Ciriaco, N., Vieites, B., Bellet, M., Castilla, C., Pardo, P. G., Pérez-Luque, A., López, M., Bofill, F. S., Alfaro, L., García, J. P., Espinosa-Bravo, M., Flannery, C., Hagen, C., & Peg, V. (2023). p119 Recurrence Score® result by the 21-gene assay before and after systemic neoadjuvant chemotherapy in patients with HR+ HER2-breast cancer.. Breast, 68, S60–. http://access.bl.uk/ark:/81055/vdc_100180198335.0x000023